The presence or absence of caspase-8 determines the invasiveness and migration of tumor cells, and decreased expression of this enzyme in women with ovarian cancer is associated with increased aggressiveness and poor prognosis due to resistance to therapy. This evidence concerns the gene CASP8 and ovarian carcinoma.